A carregar...
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting
BACKGROUND. The BALLET study was an open‐label, multicenter, expanded access study designed to allow treatment with everolimus plus exemestane in postmenopausal women with hormone receptor‐positive metastatic breast cancer progressed following prior endocrine therapy. A post hoc analysis to evaluate...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5469582/ https://ncbi.nlm.nih.gov/pubmed/28432226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0461 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|